Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

A.I. to Identify Treatment Drivers for Colorectal Cancer

Data and person graphic

A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer

Clinical Trial Underway for Lassa Fever Treatment

Lassa fever investigation

An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year. . . . → Read More: Clinical Trial Underway for Lassa Fever Treatment

Nanoscale Sponges Deliver Rheumatoid Arthritis Treatment

rheumatoid arthritis damage

An engineering lab developed a technique to load molecules from white blood cells into tiny particles that act like sponges to reduce joint damage in lab mice from rheumatoid arthritis. . . . → Read More: Nanoscale Sponges Deliver Rheumatoid Arthritis Treatment

FDA to Test New Trial Designs, Assess A.I. Models

Scott Gottlieb

FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics. . . . → Read More: FDA to Test New Trial Designs, Assess A.I. Models

Genentech Gains Modular Engineered Antibodies in $5B Deal

Natural killer cell

A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal

A.I., Imaging Shown to Predict Immunotherapy Success

Computational biology illustration

Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers. . . . → Read More: A.I., Imaging Shown to Predict Immunotherapy Success

M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

U.S. and Texas flags

M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency. . . . → Read More: M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Mountain bluebird

Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Trial Testing Cancer Treatment Delivery Compound

Erkki Ruoslahti

A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound

New Antibiotics Discovered in Stomach Peptides

Pseudomonas aeruginosa

Researchers in Italy and the U.S. found a potential source of new antibiotics in derivatives of peptides used by the digestive process in the stomach. . . . → Read More: New Antibiotics Discovered in Stomach Peptides